José Alvir

Pfizer (United States) — United States

Medicine · Health Sciences

22h-index3.8kcitations56works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(24), Functional Brain Connectivity Studies(10), Bipolar Disorder and Treatment(6), Neurological disorders and treatments(5), Treatment of Major Depression(5)

Publications56 total

Multiyear, real‐world, retrospective cohort study using a patient‐centric approach to evaluate the burden of haemophilia B in the United States
Haemophilia·2024Open Access
Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study
Journal of health economics and outcomes research·2024· 1 citedOpen Access
Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study
Journal of health economics and outcomes research·2024Open Access
Multiyear, Real-World, Retrospective Cohort Study Using a Patient-Centric Approach to Evaluate the Burden of Hemophilia B in the United States
Blood·2022
Understanding treatment patterns and patient-reported outcomes associated with the use of authorized generics and corresponding independent generics across multiple therapeutic areas
Current Medical Research and Opinion·2022· 1 citedOpen Access
The Impact of Menopausal Symptoms on Quality of Life, Productivity, and Economic Outcomes
Journal of Women s Health·2013· 291 citedOpen Access
Depression, Quality of Life, Work Productivity, Resource Use, and Costs Among Women Experiencing Menopause and Hot Flashes
The Primary Care Companion For CNS Disorders·2012· 31 citedOpen Access
The Association Between Alzheimer’s Disease Symptom Severity and Caregiver Outcomes
The Primary Care Companion For CNS Disorders·2011· 8 cited
PMH30 COSTS ASSOCIATED WITH ANTIPSYCHOTIC MEDICATIONS AT CLINICALLY RECOMMENDED DOSES BASED ON MEDICAID CLAIMS DATA FROM EIGHT STATES
Value in Health·2010
PMH40 PATTERNS OF HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH GENERALIZED ANXIETY DISORDER INITIATING ADD-ON THERAPY WITH BENZODIAZEPINES
Value in Health·2010
P.3.c.059 Association between antipsychotic treatment and clinical and economic outcomes in schizophrenia and bipolar disorder
European Neuropsychopharmacology·2009· 1 cited
Infant Television and Video Exposure Associated With Limited Parent-Child Verbal Interactions in Low Socioeconomic Status Households
Archives of Pediatrics and Adolescent Medicine·2008· 147 cited
Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects
Biological Psychiatry·2002· 90 cited
Correlates of substance misuse in patients with first‐episode schizophrenia and schizoaffective disorder
Acta Psychiatrica Scandinavica·2001· 45 cited
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder
Acta Psychiatrica Scandinavica·2001· 152 cited
Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical Correlates
American Journal of Psychiatry·2000· 907 cited
66. Left anterior hippocampal volume reductions in schizophrenia
Biological Psychiatry·1998· 3 cited
379. Symptom dimensions in first-episode schizophrenia: A longitudinal, confirmatory factor analytic study
Biological Psychiatry·1998
31. Cortical deficit and course of first-episode schizophrenia
Biological Psychiatry·1998
64. Basal ganglia volumes in schizophrenia: Implication of duration of symptoms and first line clozapine
Biological Psychiatry·1998
page 1 of 3Next →

Frequent Co-authors

John M. Kane(13), Robert M. Bilder(11), Margaret G. Woerner(11), Jeffrey A. Lieberman(10), J.A. Lieberman(9), Manzar Ashtari(8), A. Koreen(6), Delbert G. Robinson(5), David Mayerhoff(5), Miranda Chakos(5), S. Geisler(4), Brian Sheitman(4), S. Geisler(4), Antony Loebel(3), Michael Borenstein(3), J.A. Lieberman(3), Bruce L. Saltz(3), G. Reiter(2), Jennifer Whiteley(2), Marco DiBonaventura(2)